Page last updated: 2024-10-26

doxazosin and Heart Disease, Ischemic

doxazosin has been researched along with Heart Disease, Ischemic in 2 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González Maqueda, I1
Rynning, SE1
Brunvand, H1
Birkeland, S1
Hexeberg, E1
Grong, K1

Trials

1 trial available for doxazosin and Heart Disease, Ischemic

ArticleYear
Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    Coronary artery disease, 1994, Volume: 5, Issue:11

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Carbazoles; Carvedilol; Cholesterol;

1994

Other Studies

1 other study available for doxazosin and Heart Disease, Ischemic

ArticleYear
Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:3

    Topics: Adenosine; Animals; Cats; Coronary Circulation; Doxazosin; Heart; Hemodynamics; Male; Myocardial Con

1995